Rates of referable eye disease in the Scottish National Diabetic Retinopathy Screening Programme

British Journal of Ophthalmology

Volumn 98, Issue 6, 2014, Pages 790-795

  Looker, Helen C ^a   Nyangoma, S O ^a   Cromie, D T ^b   Olson, J A ^c   Leese, G P ^d   Black, M W ^e   Doig, J ^f   Lee, N ^e   Lindsay, R S ^g   McKnight, J A ^h,i   Morris, A D ^a   Pearson, D W M ^j   Philip, S ^c   Wild, S H ⁱ   Colhoun, H M ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b NHS LANARKSHIRE   (United Kingdom)

^c NHS GRAMPIAN   (United Kingdom)

^d UNIVERSITY OF DUNDEE   (United Kingdom)

^e NHS HIGHLAND   (United Kingdom)

^f FORTH VALLEY ROYAL HOSPITAL   (United Kingdom)

^g UNIVERSITY OF GLASGOW   (United Kingdom)

^h WESTERN GENERAL HOSPITAL   (United Kingdom)

ⁱ UNIVERSITY OF EDINBURGH   (United Kingdom)

^j ABERDEEN ROYAL INFIRMARY   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; DIABETIC RETINOPATHY; FEMALE; HEALTH CARE PLANNING; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT REFERRAL; PREVENTIVE MEDICINE; PRIORITY JOURNAL; PROLIFERATIVE RETINOPATHY; RETINA MACULOPATHY; RISK FACTOR;

EPIDEMIOLOGY; MACULA; RETINA;

ADULT; AGED; BLINDNESS; BLOOD PRESSURE; DATABASES, FACTUAL; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; HUMANS; MACULAR EDEMA; MALE; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; REFERRAL AND CONSULTATION; REGISTRIES; RISK FACTORS; SCOTLAND;

EID: 84901604739     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2013-303948     Document Type: Article

References (25)

1. Ghafour IM, Allan D, Foulds WS. Common causes of blindness and visual handicap in the west of Scotland. Br J Ophthalmol 1983;67:209-13. (Pubitemid 13114741)
2. Kohner EM. Diabetic retinopathy. BMJ 1993;307:1195-9.
3. Philip S, Cowie LM, Olson JA. The impact of the Health Technology Board for Scotland's grading model on referrals to ophthalmology services. Br J Ophthalmol 2005;89:891-6. (Pubitemid 40904816)
4. Scottish Diabetic Retinopathy Grading Scheme 2007; Scottish Diabetic Retinal Screening Collaborative. 2007 [cited 2013 November 22nd 2013]. http://www.ndrs.scot.nhs.uk/ClinGrp/Docs/Grading%20Scheme%202007%20v1.1.pdf
5. Pandit RJ, Taylor R. Quality assurance in screening for sight-threatening diabetic retinopathy. Diabet Med 2002;19:285-91. (Pubitemid 34592153)
6. Olson JA, Strachan FM, Hipwell JH, et al. A comparative evaluation of digital imaging, retinal photography and optometrist examination in screening for diabetic retinopathy. Diabet Med 2003;20:528-34. (Pubitemid 36886465)
7. Leese GP, Ellis JD, Morris AD, et al. Does direct ophthalmoscopy improve retinal screening for diabetic eye disease by retinal photography? Diabet Med 2002;19:867-9. (Pubitemid 35177189)
8. Murgatroyd H, Ellingford A, Cox A, et al. Effect of mydriasis and different field strategies on digital image screening of diabetic eye disease. Br J Ophthalmol 2004;88:920-4. (Pubitemid 38869555)
9. Diabetic Retinopathy Screening National Report 2009/10. NHS Scotland. 2010 [cited 2011 06 October 2011]. http://www.ndrs.scot.nhs.uk/Templates/ DRS%20Collaborative%20Annual%20Report%202009-10.pdf
10. Leese GP, Morris AD, Swaminathan K, et al. Implementation of national diabetes retinal screening programme is associated with a lower proportion of patients referred to ophthalmology. Diabet Med 2005;22:1112-15. (Pubitemid 41026013)
11. Looker HC, Nyangoma SO, Cromie DT, et al. Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programme. Diabetologia 2013;56:1716-25.
12. Elman MJ, Aiello LP, Beck RW, et al. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology 2010;117:1064-77 e35.
13. ranibizumab, 10 mg/mL solution for injection (Lucentis®) SMC No. (711/11). Scottish Medicines Consortium; 2012 [cited 2013 1st May 2013]; Advice from Scottish Medicines Consortium on use of ranibizumab for macula oedema]. http://www.scottishmedicines.org.uk/files/advice/ranibizumab-Lucentis- Resubmission-FINAL-November-2012-for-website.pdf
14. Klein R, Klein BE, Moss SE, et al. The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1984;102:520-6. (Pubitemid 14127838)
15. Looker HC, Nyangoma SO, Cromie D, et al. Diabetic retinopathy at diagnosis of type 2 diabetes in Scotland. Diabetologia 2012;55:2335-42.
16. Misra A, Bachmann MO, Greenwood RH, et al. Trends in yield and effects of screening intervals during 17 years of a large UK community-based diabetic retinopathy screening programme. Diabet Med 2009;26:1040-7.
17. Cheng YJ, Gregg EW, Geiss LS, et al. Association of A1C and fasting plasma glucose levels with diabetic retinopathy prevalence in the U.S. population: implications for diabetes diagnostic thresholds. Diabetes Care 2009;32:2027-32.
18. Klein R, Klein BE, Moss SE, et al. The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 1984;102:527-32. (Pubitemid 14127839)
19. Zhang L, Krzentowski G, Albert A, et al. Risk of developing retinopathy in Diabetes Control and Complications Trial type 1 diabetic patients with good or poor metabolic control. Diabetes Care 2001;24:1275-9. (Pubitemid 33716411)
20. van Leiden HA, Dekker JM, Moll AC, et al. Blood pressure, lipids, and obesity are associated with retinopathy: the hoorn study. Diabetes Care 2002;25:1320-5. (Pubitemid 41071139)
21. Klein R, Klein BE, Moss SE. Is obesity related to microvascular and macrovascular complications in diabetes? The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch Intern Med 1997;157:650-6. (Pubitemid 27133195)
22. Hammes HP, Kerner W, Hofer S, et al. Diabetic retinopathy in type 1 diabetes-a contemporary analysis of 8,784 patients. Diabetologia 2011;54:1977-84.
23. Stratton IM, Kohner EM, Aldington SJ, et al. UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis. Diabetologia 2001;44:156-63. (Pubitemid 32156199)
24. Roy MS, Klein R, O'Colmain BJ, et al. The prevalence of diabetic retinopathy among adult type 1 diabetic persons in the United States. Arch Ophthalmol 2004;122:546-51. (Pubitemid 38456291)
25. LeCaire TJ, Palta M, Klein R, et al. Assessing progress in retinopathy outcomes in type 1 diabetes: comparing findings from the Wisconsin Diabetes Registry Study and the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Diabetes Care 2013;36:631-7.